Diebold Nixdorf, Incorporated DBD
62.72
0.25
0.40%
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 20.2×
Follow DBD
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
4.62% | 9.26% | 10.70% | 10.68% | |
| 1.33% | 2.56% | 2.89% | 2.97% | ||
ROIC |
7.10% | 9.30% | 9.62% | 9.40% | |
Return on Tangible Assets |
6.97% | 13.49% | 15.66% | 16.66% | |
Average Days of Receivables |
57.37 | 64.14 | 56.50 | 61.48 | |
Free Cash Flow per Share |
6.29 | 6.49 | 7.23 | 6.16 | |
Free Cash Flow |
229.50 | 239.00 | 253.60 | 212.00 | |
Capital Expenditures |
(49.90) | (61.70) | (63.10) | (61.00) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
12.01% | 12.23% | 13.54% | 12.40% | |
Accounts Receivable Turnover |
5.93 | 6.05 | 6.43 | 6.19 | |
Accounts Payable Turnover |
5.90 | 6.38 | 6.19 | 6.17 | |
Inventory Turnover |
4.48 | 5.42 | 5.22 | 4.95 | |
Average Days of Payables |
60.68 | 55.32 | 61.07 | 63.83 | |
Days of Inventory on Hand |
78.81 | 66.85 | 69.99 | 75.14 | |
Tax Rate |
(0.26) | (0.19) | (0.22) | (0.28) | |
Research and Development Expense of Revenue |
2.42% | 2.28% | 2.23% | 2.17% | |
Selling, General and Administrative Expense of Revenue |
16.86% | 16.62% | 16.54% | 16.68% | |
Share Based Compensation of Revenue |
0.31% | 0.32% | 0.32% | 0.34% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
5.52 | 3.18 | 2.94 | 2.46 | |
Depreciation/Fixed assets |
0.52 | 0.47 | 0.45 | 0.43 | |
Capex/Depreciation |
(0.36) | (0.46) | (0.48) | (0.46) | |
Revenue per Share |
101.11 | 103.42 | 109.87 | 112.56 | |
Operating CF per Share |
7.65 | 8.17 | 9.02 | 7.94 | |
Capex per Share |
(1.37) | (1.68) | (1.80) | (1.77) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
1.37% | 2.49% | 2.80% | 2.87% |
Columns are period end dates